# Intellia Therapeutics

**Source:** https://www.startuphub.ai/startups/intellia-therapeutics-inc
**Profile type:** Startup

> A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

## About

Intellia Therapeutics is a leading clinical-stage genome editing company focused on developing curative therapeutics using its proprietary CRISPR/Cas9 technology. The company aims to precisely edit genes within the body to treat a range of severe diseases, including genetic disorders and cancer, offering potentially transformative treatments for patients.

## Key facts

- **Slug:** intellia-therapeutics-inc
- **Website:** https://www.intelliatx.com
- **Location:** Cambridge, United States
- **Founded:** 2014-05-01
- **Operating status:** Active
- **Total funding:** $310M
- **Sectors / tags:** Biotech, MedTech, Genomics, Drug Discovery, Clinical Trials, CRISPR, Gene Editing, Genetic Disorders, Oncology, Rare Diseases, In Vivo Gene Editing, Ex Vivo Gene Editing
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/intelliatx
  - Twitter: https://twitter.com/intelliatx

## Frequently asked

### What does Intellia Therapeutics do?

Intellia Therapeutics is a leading clinical-stage genome editing company focused on developing curative therapeutics using its proprietary CRISPR/Cas9 technology. The company aims to precisely edit genes within the body to treat a range of severe diseases, including genetic disorders and cancer, offering potentially transformative treatments for patients.

### What is Intellia Therapeutics's revenue?

StartupHub estimates Intellia Therapeutics's annual revenue at $128.6M (range $18.0M to $307.6M, 29% confidence), based on comparable companies in the sector.

### What is Intellia Therapeutics's valuation?

StartupHub estimates Intellia Therapeutics's effective valuation at $1.1B (range $775.0M to $1.9B, 10% confidence), based on comparable companies in the sector.

### How much funding has Intellia Therapeutics raised?

Intellia Therapeutics has raised a total of $310M in funding. The most recent round on record is Series C.

### Where is Intellia Therapeutics headquartered?

Intellia Therapeutics is headquartered in Cambridge, United States.

### When was Intellia Therapeutics founded?

Intellia Therapeutics was founded in 2014.

### What industry does Intellia Therapeutics operate in?

Intellia Therapeutics operates in Biotech, MedTech, Genomics, Drug Discovery, Clinical Trials, CRISPR.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Intellia Therapeutics",
          "item": "https://www.startuphub.ai/startups/intellia-therapeutics-inc"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/intellia-therapeutics-inc#webpage",
      "url": "https://www.startuphub.ai/startups/intellia-therapeutics-inc",
      "name": "Intellia Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Intellia Therapeutics. Intellia Therapeutics is a startup founded in 2014, operating in Biotech and MedTech. A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases. Headquartered in Cambridge, United States.",
      "dateModified": "2026-08-01T09:45:10.536+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/intellia-therapeutics-inc#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/intellia-therapeutics-inc#organization",
      "name": "Intellia Therapeutics",
      "url": "https://www.intelliatx.com",
      "description": "This is the official profile of Intellia Therapeutics. Intellia Therapeutics is a startup founded in 2014, operating in Biotech and MedTech. A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases. Headquartered in Cambridge, United States.",
      "sameAs": [
        "https://www.linkedin.com/company/intelliatx",
        "https://twitter.com/intelliatx",
        "https://www.startuphub.ai/startups/intellia-therapeutics-inc"
      ],
      "foundingDate": "2014-05-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Cambridge",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotech",
        "MedTech",
        "Genomics",
        "Drug Discovery",
        "Clinical Trials",
        "CRISPR",
        "Gene Editing",
        "Genetic Disorders",
        "Oncology",
        "Rare Diseases",
        "In Vivo Gene Editing",
        "Ex Vivo Gene Editing"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/intellia-therapeutics-inc#profile-assessment",
      "name": "Intellia Therapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/intellia-therapeutics-inc",
      "category": "Biotech",
      "description": "This is the official profile of Intellia Therapeutics. Intellia Therapeutics is a startup founded in 2014, operating in Biotech and MedTech. A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases. Headquartered in Cambridge, United States.",
      "brand": {
        "@type": "Brand",
        "name": "Intellia Therapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-08-01",
        "name": "Intellia Therapeutics - Profile Score 36/100",
        "reviewBody": "This is the official profile of Intellia Therapeutics. Intellia Therapeutics is a startup founded in 2014, operating in Biotech and MedTech. A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases. Headquartered in Cambridge, United States.",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 36,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```